Literature DB >> 32639515

Bayesian Pathway Analysis for Complex Interactions.

James W Baurley, Anders Kjærsgaard, Michael E Zwick, Deirdre P Cronin-Fenton, Lindsay J Collin, Per Damkier, Stephen Hamilton-Dutoit, Timothy L Lash, Thomas P Ahern.   

Abstract

Modern epidemiologic studies permit investigation of the complex pathways that mediate effects of social, behavioral, and molecular factors on health outcomes. Conventional analytical approaches struggle with high-dimensional data, leading to high likelihoods of both false-positive and false-negative inferences. Herein, we describe a novel Bayesian pathway analysis approach, the algorithm for learning pathway structure (ALPS), which addresses key limitations in existing approaches to complex data analysis. ALPS uses prior information about pathways in concert with empirical data to identify and quantify complex interactions within networks of factors that mediate an association between an exposure and an outcome. We illustrate ALPS through application to a complex gene-drug interaction analysis in the Predictors of Breast Cancer Recurrence (ProBe CaRe) Study, a Danish cohort study of premenopausal breast cancer patients (2002-2011), for which conventional analyses severely limit the quality of inference.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bayesian analysis; breast neoplasms; pharmacogenetics; tamoxifen

Mesh:

Substances:

Year:  2020        PMID: 32639515      PMCID: PMC7822643          DOI: 10.1093/aje/kwaa130

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  29 in total

1.  BhGLM: Bayesian hierarchical GLMs and survival models, with applications to genomics and epidemiology.

Authors:  Nengjun Yi; Zaixiang Tang; Xinyan Zhang; Boyi Guo
Journal:  Bioinformatics       Date:  2019-04-15       Impact factor: 6.937

2.  Discovery of complex pathways from observational data.

Authors:  James W Baurley; David V Conti; W James Gauderman; Duncan C Thomas
Journal:  Stat Med       Date:  2010-08-30       Impact factor: 2.373

3.  Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.

Authors:  Young Chai Lim; Zeruesenay Desta; David A Flockhart; Todd C Skaar
Journal:  Cancer Chemother Pharmacol       Date:  2005-02-01       Impact factor: 3.333

4.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

5.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

6.  Commentary: The Limits of Risk Factors Revisited: Is It Time for a Causal Architecture Approach?

Authors:  Katherine M Keyes; Sandro Galea
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

7.  Elimination of antiestrogenic effects of active tamoxifen metabolites by glucuronidation.

Authors:  Yan Zheng; Dongxiao Sun; Arun K Sharma; Gang Chen; Shantu Amin; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2007-07-09       Impact factor: 3.922

Review 8.  Pharmacogenomics: Precision Medicine and Drug Response.

Authors:  Richard M Weinshilboum; Liewei Wang
Journal:  Mayo Clin Proc       Date:  2017-11-01       Impact factor: 7.616

Review 9.  Molecular mechanism of estrogen-estrogen receptor signaling.

Authors:  Pelin Yaşar; Gamze Ayaz; Sırma Damla User; Gizem Güpür; Mesut Muyan
Journal:  Reprod Med Biol       Date:  2016-12-05

Review 10.  Pathways to Endocrine Therapy Resistance in Breast Cancer.

Authors:  Md Moquitul Haque; Kartiki V Desai
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-21       Impact factor: 5.555

View more
  1 in total

1.  Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.

Authors:  Cathrine F Hjorth; Per Damkier; Tore B Stage; Søren Feddersen; Stephen Hamilton-Dutoit; Mikael Rørth; Bent Ejlertsen; Timothy L Lash; Thomas P Ahern; Henrik T Sørensen; Deirdre Cronin-Fenton
Journal:  Breast Cancer Res Treat       Date:  2022-04-30       Impact factor: 4.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.